Walleye Capital LLC Apellis Pharmaceuticals, Inc. Transaction History

Walleye Capital LLC

$24 Billion
Q3 2025

A detailed history of Walleye Capital LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Walleye Capital LLC holds 142,158 shares of APLS stock, worth $2.89 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

142,158

Previous 19,900 614.36%

Holding current value

$2.89 Million

Previous $344,000 835.17%

% of portfolio

0.01%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$17.42 - $28.65 $1.06 Million - $1.74 Million	60,888 Added 74.92%	142,158 $3.22 Million
Q2 2025 Aug 13, 2025	SELL	$16.36 - $23.0 $3.86 Million - $5.43 Million	-236,172 Reduced 74.4%	81,270 $1.41 Million
Q1 2025 May 14, 2025	SELL	$21.87 - $34.63 $1.69 Million - $2.68 Million	-77,381 Reduced 19.6%	317,442 $6.94 Million
Q4 2024 Feb 13, 2025	BUY	$26.18 - $35.42 $7.66 Million - $10.4 Million	292,743 Added 286.78%	394,823 $12.6 Million
Q3 2024 Nov 14, 2024	BUY	$28.84 - $41.15 $1.48 Million - $2.12 Million	51,441 Added 101.58%	102,080 $2.94 Million

Q2 2024 Aug 14, 2024	SELL	$38.07 - $59.71 $2.29 Million - $3.59 Million	-60,160 Reduced 54.3%	50,639 $1.94 Million
Q1 2024 May 15, 2024	SELL	$55.39 - $72.47 $2.04 Million - $2.67 Million	-36,875 Reduced 24.97%	110,799 $6.51 Million
Q4 2023 Feb 14, 2024	BUY	$37.14 - $64.82 $508,483 - $887,450	13,691 Added 10.22%	147,674 $8.84 Million
Q3 2023 Nov 14, 2023	BUY	$23.65 - $89.22 $1.8 Million - $6.79 Million	76,074 Added 131.37%	133,983 $5.1 Million
Q2 2023 Aug 14, 2023	SELL	$76.68 - $93.31 $4.71 Million - $5.74 Million	-61,469 Reduced 51.49%	57,909 $5.28 Million
Q1 2023 May 15, 2023	BUY	$46.59 - $66.96 $5.56 Million - $7.99 Million	119,378 New	119,378 $7.87 Million
Q2 2022 Aug 08, 2022	SELL	$35.07 - $59.21 $444,933 - $751,197	-12,687 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$35.46 - $54.12 $3.63 Million - $5.54 Million	-102,446 Reduced 88.98%	12,687 $645,000
Q4 2021 Mar 03, 2022	BUY	$30.74 - $49.16 $3.54 Million - $5.66 Million	115,133 New	115,133 $5.44 Million

Others Institutions Holding APLS

# of Institutions

329

Shares Held

124M

Call Options Held

4.12M

Put Options Held

756K

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $2.23B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Account

Walleye Capital LLC Apellis Pharmaceuticals, Inc. Transaction History